Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Capital Market

27.35USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$27.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
114,548
52-wk High
$30.35
52-wk Low
$2.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.735
Mar '17 0.00 -0.732
FY 2016 Dec '16 0.00 -0.990
Sep '16 0.00 -0.975
Jun '16 0.00 -1.108
Mar '16 0.00 -1.131
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 6 1.97 8.50 0.00 37.00
Earnings (per share)
Quarter Ending Mar-18 4 -0.62 -0.45 -0.79 --
Quarter Ending Jun-18 4 -0.65 -0.46 -0.87 --
Year Ending Dec-18 7 -2.36 -1.58 -3.53 -2.67
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 1.68 0.90 0.89
Price to Sales (TTM) -- 110.72 5.77
Price to Book (MRQ) 4.36 13.56 5.41
Price to Tangible Book (MRQ) 4.36 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 65.71 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 33.65 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 20.31 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 12.20 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 7.86 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -- -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -- -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -- -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,602,121 855,668,157
Net Income/Employee (TTM) -1,448,615 2,968,747 100,655,595
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.89 -1.05 10.98
Return on Assets - 5 Yr. Avg. -84.50 -0.57 12.37
Return on Investment (TTM) -91.06 1.66 14.43
Return on Investment - 5 Yr. Avg. -108.20 2.23 16.18
Return on Equity (TTM) -91.23 2.58 16.13
Return on Equity - 5 Yr. Avg. -108.28 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -10.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mirati Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 85.87%
# of Holders: 82
Total Shares Held: 23,179,202
3 Mo. Net Change: 5,437,899
# New Positions: 29
# Closed Positions: 13
# Increased Positions: 51
# Reduced Positions: 27
# Net Buyers: 24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.